CoChat
Sign Up
Cited by 2,553Functional Brain Connectivity StudiesComplex Network Analysis TechniquesAdvanced Neuroimaging Techniques and Applications

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Efficiency and Cost of Economical Brain Functional Networks

Open access
Achard, Sophie, Bullmore, Ed·2007·PLoS Computational Biology
DOI 10.1371/journal.pcbi.0030017PMC PMC1794324
Open this paper in CoChat — free accountOpen PDF

Abstract

Brain anatomical networks are sparse, complex, and have economical small-world properties. We investigated the efficiency and cost of human brain functional networks measured using functional magnetic resonance imaging (fMRI) in a factorial design: two groups of healthy old (N = 11; mean age = 66.5 years) and healthy young (N = 15; mean age = 24.7 years) volunteers were each scanned twice in a no-task or "resting" state following placebo or a single dose of a dopamine receptor antagonist (sulpiride 400 mg). Functional connectivity between 90 cortical and subcortical regions was estimated by wavelet correlation analysis, in the frequency interval 0.06-0.11 Hz, and thresholded to construct undirected graphs. These brain functional networks were small-world and economical in the sense of providing high global and local efficiency of parallel information processing for low connection cost. Efficiency was reduced disproportionately to cost in older people, and the detrimental effects of age on efficiency were localised to frontal and temporal cortical and subcortical regions. Dopamine antagonism also impaired global and local efficiency of the network, but this effect was differentially localised and did not interact with the effect of age. Brain functional networks have economical small-world properties-supporting efficient parallel information transfer at relatively low cost-which are differently impaired by normal aging and pharmacological blockade of dopamine transmission.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pcbi.0030017

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Small-World Properties of Human Brain Functional Networks Global and local efficiency (y-axis) as a function of cost (x-axis) for a random graph, a regular lattice, and brain networks. For all networks, global and local efficiency increase with cost; the random graph has greater global efficiency than the lattice; the lattice has greater local efficiency than the random graph. On average, over all subjects in each group, young brain networks (black broken lines) and old brain networks (red broken lines) have efficiency curves located between the limiting cases of random and lattice topology. The small-world regime is conservatively defined as the range of costs 0.34 ≤ K ≤ 0.5 for which the global efficiency curve for the old networks is greater than the global efficiency curve for the lattice.
Figure 1 Small-World Properties of Human Brain Functional Networks Global and local efficiency (y-axis) as a function of cost (x-axis) for a random graph, a regular lattice, and brain networks. For all networks, global and local efficiency increase with cost; the random graph has greater global efficiency than the lattice; the lattice has greater local efficiency than the random graph. On average, over all subjects in each group, young brain networks (black broken lines) and old brain networks (red broken lines) have efficiency curves located between the limiting cases of random and lattice topology. The small-world regime is conservatively defined as the range of costs 0.34 ≤ K ≤ 0.5 for which the global efficiency curve for the old networks is greater than the global efficiency curve for the lattice.CC BY · PubMed Central
Figure 2 Economical Properties of Human Brain Functional Networks Efficiency (y-axis) as a function of cost (x-axis) for two individual brain networks: a young subject following placebo (left panel) and an older subject following placebo (right panel). For both subjects, local efficiency (red lines) and global efficiency (green lines) increase monotonically with cost; and cost efficiency (the difference between global efficiency and cost; blue lines) has its maximum value when 0.2 ≤ K ≤ 0.4. The low-cost threshold, K ∼ 0.1, associated with the sparse networks reported in Figures 3 and 5, is shown as a black vertical line in each graph.
Figure 2 Economical Properties of Human Brain Functional Networks Efficiency (y-axis) as a function of cost (x-axis) for two individual brain networks: a young subject following placebo (left panel) and an older subject following placebo (right panel). For both subjects, local efficiency (red lines) and global efficiency (green lines) increase monotonically with cost; and cost efficiency (the difference between global efficiency and cost; blue lines) has its maximum value when 0.2 ≤ K ≤ 0.4. The low-cost threshold, K ∼ 0.1, associated with the sparse networks reported in Figures 3 and 5, is shown as a black vertical line in each graph.CC BY · PubMed Central
Figure 3 Efficiency Measures for Low-Cost Brain Functional Networks, with K ∼ 0.1, in All Participants (Top row) Within-subject effects of dopamine antagonism (sulpiride 400 mg) on global efficiency (left column), local efficiency (middle column), and maximum cost efficiency (right column): data on younger subjects are denoted by black lines and black triangles, data on older subjects by red lines and red triangles. (Bottom row) Box-plots showing median, interquartile range, and range for global efficiency, local efficiency, and maximum-cost efficiency in each age group after each treatment. Each horizontal line and the associated number represent the p-value of a post-hoc t-test: there were consistent pairwise differences in global efficiency related to age (YP–OP and YS–OS), less consistent age-related differences in cost efficiency (YP–OP), and no significant post-hoc effects of age on local efficiency; however, there were consistent pairwise differences in local efficiency related to drug treatment (YP–YS and OP–OS), and a significant effect of drug on global efficiency in young people (YP–YS).
Figure 3 Efficiency Measures for Low-Cost Brain Functional Networks, with K ∼ 0.1, in All Participants (Top row) Within-subject effects of dopamine antagonism (sulpiride 400 mg) on global efficiency (left column), local efficiency (middle column), and maximum cost efficiency (right column): data on younger subjects are denoted by black lines and black triangles, data on older subjects by red lines and red triangles. (Bottom row) Box-plots showing median, interquartile range, and range for global efficiency, local efficiency, and maximum-cost efficiency in each age group after each treatment. Each horizontal line and the associated number represent the p-value of a post-hoc t-test: there were consistent pairwise differences in global efficiency related to age (YP–OP and YS–OS), less consistent age-related differences in cost efficiency (YP–OP), and no significant post-hoc effects of age on local efficiency; however, there were consistent pairwise differences in local efficiency related to drug treatment (YP–YS and OP–OS), and a significant effect of drug on global efficiency in young people (YP–YS).CC BY · PubMed Central
Figure 4 Efficiency Measures Estimated and Integrated over the Small-World Regime of Network Costs, 0.05 ≤ K ≤ 0.34 (Rows 1,2) Global (left) and local (right) efficiency curves for young (black lines) and older (red lines) people after placebo (row 1) and sulpiride (row 2). (Row 3) Within-subject effects of dopamine antagonism on integrated global efficiency (left) and integrated local efficiency (right): data on younger subjects are denoted by black lines and black triangles, data on older subjects by red lines and red triangles. (Row 4) Box-plots showing median, interquartile range, and range for integrated global efficiency (left) and integrated local efficiency (right) in each age group after each treatment.
Figure 4 Efficiency Measures Estimated and Integrated over the Small-World Regime of Network Costs, 0.05 ≤ K ≤ 0.34 (Rows 1,2) Global (left) and local (right) efficiency curves for young (black lines) and older (red lines) people after placebo (row 1) and sulpiride (row 2). (Row 3) Within-subject effects of dopamine antagonism on integrated global efficiency (left) and integrated local efficiency (right): data on younger subjects are denoted by black lines and black triangles, data on older subjects by red lines and red triangles. (Row 4) Box-plots showing median, interquartile range, and range for integrated global efficiency (left) and integrated local efficiency (right) in each age group after each treatment.CC BY · PubMed Central
Figure 5 Effect of Age on Regional Efficiency Brain regions ranked in order of decreasing regional efficiency: “hubs” have high regional efficiency and tend to be larger regions of association cortex in both young (left panel) and old people (right panel); “diaspora” have low regional efficiency and tend to be smaller regions of limbic/paralimbic cortex. Each box-plot shows median, interquartile range, and range for individual estimates of regional efficiency in each age group following placebo; boxes are color-coded to differentiate primary sensory or motor cortex (red), unimodal or multimodal association cortex (beige), limbic or paralimbic cortex (turquoise blue), and subcortical nuclei (periwinkle blue).
Figure 5 Effect of Age on Regional Efficiency Brain regions ranked in order of decreasing regional efficiency: “hubs” have high regional efficiency and tend to be larger regions of association cortex in both young (left panel) and old people (right panel); “diaspora” have low regional efficiency and tend to be smaller regions of limbic/paralimbic cortex. Each box-plot shows median, interquartile range, and range for individual estimates of regional efficiency in each age group following placebo; boxes are color-coded to differentiate primary sensory or motor cortex (red), unimodal or multimodal association cortex (beige), limbic or paralimbic cortex (turquoise blue), and subcortical nuclei (periwinkle blue).CC BY · PubMed Central
Figure 6 Anatomical Representation of Brain Functional Networks Highlighting Regional Effects of Age and Dopamine Receptor Antagonism Brain functional networks for one young person following placebo (top row) and one old person following placebo (bottom row). These networks were constructed by thresholding the individual wavelet correlation matrices to derive sparse networks with equal cost, K ∼ 0.1: regional nodes are shown as dots or circles in a sagittal view of the right side of the brain; strong functional connections are shown as undirected edges between nodes. The size of regional nodes is proportional to the significance of age-related or drug-related reductions in regional efficiency: red nodes, efficiency reduced by older age; blue nodes, efficiency reduced by sulpiride; purple nodes, efficiency reduced by both older age and sulpiride. See Table 2 for anatomical detail concerning locations of significant difference in regional efficiency.
Figure 6 Anatomical Representation of Brain Functional Networks Highlighting Regional Effects of Age and Dopamine Receptor Antagonism Brain functional networks for one young person following placebo (top row) and one old person following placebo (bottom row). These networks were constructed by thresholding the individual wavelet correlation matrices to derive sparse networks with equal cost, K ∼ 0.1: regional nodes are shown as dots or circles in a sagittal view of the right side of the brain; strong functional connections are shown as undirected edges between nodes. The size of regional nodes is proportional to the significance of age-related or drug-related reductions in regional efficiency: red nodes, efficiency reduced by older age; blue nodes, efficiency reduced by sulpiride; purple nodes, efficiency reduced by both older age and sulpiride. See Table 2 for anatomical detail concerning locations of significant difference in regional efficiency.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. LezakMD 1995 Neuropsychological assessment New York Oxford University Press 1026

Cited by

Sorted by citations

See all 2,553

Related

See all

Metadata

Authors
Achard, S., & Bullmore, E.
Affiliations
University of Cambridge (GB)
ORCID
Achard, Sophie
Venue
PLoS Computational Biology
Publisher
Public Library of Science (PLoS)
Published
2007-02-02
Volume
3
Issue
2
Pages
e17
ISSN
  • 1553-734X (ISSN-L)
  • 1553-7358
DOI
10.1371/journal.pcbi.0030017
PMC
PMC1794324
OpenAlex
W1974764791
Cited by
2,553
References
55
Citations by year
2026: 103 · 2025: 147 · 2024: 150 · 2023: 142 · 2022: 162 · 2021: 201 · 2020: 169 · 2019: 162 · 2018: 185 · 2017: 175 · 2016: 157 · 2015: 144 · 2014: 130 · 2013: 143 · 2012: 115
FWCI
26.22
Type
journal article
Language
en
Open access
Licence
Locations
  • PLoS Computational Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Wellcome Trust
  • Medical Research Council
  • National Institute of Mental Health
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
  • Physical Sciences › Physics and Astronomy › Statistical and Nonlinear Physics › Complex Network Analysis Techniques
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
Keywords
functional brain networks, small-world networks, network efficiency, network cost, aging, sulpiride, dopamine receptor antagonism, functional connectivity, resting state, wavelet correlation, graph theory, frontal cortex, temporal cortex, subcortical structures
MeSH terms
Adult, Aged, Aging, Brain, Brain Mapping, Computer Simulation, Female, Humans, Magnetic Resonance Imaging, Male, Models, Neurological, Nerve Net, Neurons, Dopamine Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review